Metastatic Colorectal Cancer Pipeline Drugs Analysis Report (2023 Updates): FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Hutchison Medipharma, Isofol Medical, Sumitomo Dainippon Pharma, G1 Therapeutics, Merck, AB Science, Pfizer,

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Metastatic Colorectal Cancer pipeline constitutes 130+ key companies continuously working towards developing 140+ Metastatic Colorectal Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Metastatic Colorectal Cancer Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Metastatic Colorectal Cancer Market.

The Metastatic Colorectal Cancer Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Metastatic Colorectal Cancer Pipeline Report: https://www.delveinsight.com/sample-request/metastatic-colorectal-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Metastatic Colorectal Cancer treatment therapies with a considerable amount of success over the years.
• Metastatic Colorectal Cancer companies working in the treatment market are Plus Therapeutics, Processa Pharmaceutic als, Shanghai Henlius Biotech, Genor Biopharma, Novartis Pharmaceutical, Sumitomo Pharma Oncology, Purple Biotech Ltd., Nektar Therapeutics, ALX Oncology Inc., Sunshine Guojian Pharmaceutic al, deruxtecan Daiichi Sankyo, Gritstone Bio, Inc., Suzhou Suncadia Biopharmaceuti cals Co., Ltd., Amgen, G1 Therapeutic s, Inc., and others, are developing therapies for the Metastatic Colorectal Cancer treatment
• Emerging Metastatic Colorectal Cancer therapies in the different phases of clinical trials are- 188RNL-BAM, PCS11T, HLX13, Geptanolimab, HDM201, TP-1454, NT219, NKTR-255, Evorpacept (ALX148), CPGJ 602, Trastuzumab, GRT-C901, SHR-1701, Lumakras (sotorasib), Trilaciclib, and others are expected to have a significant impact on the Metastatic Colorectal Cancer market in the coming years.
• In March 2022, ALX Oncology Inc., in partnership with Merck Sharp & Dohme Corp. and Eli Lilly and Company, is set to commence a Phase II Study (with Safety Run-in) focusing on ALX148 combined with Cetuximab and Pembrolizumab for patients diagnosed with Refractory Microsatellite Stable Metastatic Colorectal Cancer.
• In October 2020, G1 Therapeutics has commenced a Phase 3 Randomized, Double-blind Trial comparing Trilaciclib against Placebo in individuals receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer. Patients will be randomly allocated (1:1) to receive either placebo or trilaciclib intravenously (IV) on Days 1 and 2 before FOLFOXIRI/bevacizumab in 14-day cycles for a maximum of 12 cycles (Induction).

Metastatic Colorectal Cancer Overview
The majority of people with colorectal cancer (CRC), which is the third most frequent kind of cancer, die primarily from metastases. Both the liver and the peritoneum are common locations for distant metastases. The colon or the rectm is where CRC begins. These tumors may also be referred to as rectal or colon cancer, depending on where they originate.

Get a Free Sample PDF Report to know more about Metastatic Colorectal Cancer Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/metastatic-colorectal-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Emerging Metastatic Colorectal Cancer Drugs Under Different Phases of Clinical Development Include:
• 188RNL-BAM: Plus Therapeutics
• PCS11T: Processa Pharmaceutic als
• HLX13: Shanghai Henlius Biotech
• Geptanolimab: Genor Biopharma
• HDM201: Novartis Pharmaceutical
• TP-1454: Sumitomo Pharma Oncology
• NT219: Purple Biotech Ltd.
• NKTR-255: Nektar Therapeutics
• Evorpacept (ALX148): ALX Oncology Inc.
• CPGJ 602: Sunshine Guojian Pharmaceutic al
• Trastuzumab: deruxtecan Daiichi Sankyo
• GRT-C901: Gritstone Bio, Inc.
• SHR-1701: Suzhou Suncadia Biopharmaceuti cals Co., Ltd.
• Lumakras (sotorasib): Amgen
• Trilaciclib: G1 Therapeutic s, Inc.

Metastatic Colorectal Cancer Pipeline Therapeutics Assessment
• Metastatic Colorectal Cancer Assessment by Product Type
• Metastatic Colorectal Cancer By Stage and Product Type
• Metastatic Colorectal Cancer Assessment by Route of Administration
• Metastatic Colorectal Cancer By Stage and Route of Administration
• Metastatic Colorectal Cancer Assessment by Molecule Type
• Metastatic Colorectal Cancer by Stage and Molecule Type

DelveInsight's Metastatic Colorectal Cancer Report covers around 140+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Metastatic Colorectal Cancer product details are provided in the report. Download the Metastatic Colorectal Cancer pipeline report to learn more about the emerging Metastatic Colorectal Cancer therapies at:
https://www.delveinsight.com/sample-request/metastatic-colorectal-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key companies in the Metastatic Colorectal Cancer Therapeutics Market include:
Key companies developing therapies for Metastatic Colorectal Cancer are - Hutchison Medipharma, Isofol Medical, Sumitomo Dainippon Pharma, G1 Therapeutics, Merck, AB Science, Pfizer, Daiichi Sankyo, AstraZeneca, Eisai, Mirati Therapeutics, Cardiff Oncology, and others.

Metastatic Colorectal Cancer Pipeline Analysis:
The Metastatic Colorectal Cancer pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Metastatic Colorectal Cancer with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Metastatic Colorectal Cancer Treatment.
• Metastatic Colorectal Cancer key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Metastatic Colorectal Cancer Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Metastatic Colorectal Cancer market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Metastatic Colorectal Cancer drugs and therapies-
https://www.delveinsight.com/sample-request/metastatic-colorectal-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Metastatic Colorectal Cancer Pipeline Market Drivers
• Emergence of targeted therapies for mCRC treatment, technical Advancement in molecular subtyping of CRC tumors, increase in product development activities are some of the important factors that are fueling the Metastatic Colorectal Cancer Market.

Metastatic Colorectal Cancer Pipeline Market Barriers
• However, limitations in understanding secondary resistance, challenges related to precision oncology in mCRC management and other factors are creating obstacles in the Metastatic Colorectal Cancer Market growth.

Scope of Metastatic Colorectal Cancer Pipeline Drug Insight
• Coverage: Global
• Key Metastatic Colorectal Cancer Companies: Plus Therapeutics, Processa Pharmaceutic als, Shanghai Henlius Biotech, Genor Biopharma, Novartis Pharmaceutical, Sumitomo Pharma Oncology, Purple Biotech Ltd., Nektar Therapeutics, ALX Oncology Inc., Sunshine Guojian Pharmaceutic al, deruxtecan Daiichi Sankyo, Gritstone Bio, Inc., Suzhou Suncadia Biopharmaceuti cals Co., Ltd., Amgen, G1 Therapeutic s, Inc., and others
• Key Metastatic Colorectal Cancer Therapies: 188RNL-BAM, PCS11T, HLX13, Geptanolimab, HDM201, TP-1454, NT219, NKTR-255, Evorpacept (ALX148), CPGJ 602, Trastuzumab, GRT-C901, SHR-1701, Lumakras (sotorasib), Trilaciclib, and others
• Metastatic Colorectal Cancer Therapeutic Assessment: Metastatic Colorectal Cancer current marketed and Metastatic Colorectal Cancer emerging therapies
• Metastatic Colorectal Cancer Market Dynamics: Metastatic Colorectal Cancer market drivers and Metastatic Colorectal Cancer market barriers

Request for Sample PDF Report for Metastatic Colorectal Cancer Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/metastatic-colorectal-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Metastatic Colorectal Cancer Report Introduction
2. Metastatic Colorectal Cancer Executive Summary
3. Metastatic Colorectal Cancer Overview
4. Metastatic Colorectal Cancer- Analytical Perspective In-depth Commercial Assessment
5. Metastatic Colorectal Cancer Pipeline Therapeutics
6. Metastatic Colorectal Cancer Late Stage Products (Phase II/III)
7. Metastatic Colorectal Cancer Mid Stage Products (Phase II)
8. Metastatic Colorectal Cancer Early Stage Products (Phase I)
9. Metastatic Colorectal Cancer Preclinical Stage Products
10. Metastatic Colorectal Cancer Therapeutics Assessment
11. Metastatic Colorectal Cancer Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Metastatic Colorectal Cancer Key Companies
14. Metastatic Colorectal Cancer Key Products
15. Metastatic Colorectal Cancer Unmet Needs
16 . Metastatic Colorectal Cancer Market Drivers and Barriers
17. Metastatic Colorectal Cancer Future Perspectives and Conclusion
18. Metastatic Colorectal Cancer Analyst Views
19. Appendix
20. About DelveInsight

Related Reports:

Metastatic Colorectal Cancer Market https://www.delveinsight.com/report-store/metastatic-colorectal-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Metastatic Colorectal Cancer Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Metastatic Colorectal Cancer Epidemiology https://www.delveinsight.com/report-store/metastatic-colorectal-cancer-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Metastatic Colorectal Cancer Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports:
Ventricular Assist Devices Market https://www.delveinsight.com/report-store/ventricular-assist-devices-vad-market
Ventricular Assist Devices Market By Product Type (Left Ventricular Assist Devices, Right Ventricular Assist Devices, And Biventricular Assist Devices), By Application Type (Bridge-To-Transplant [Btt], Destination Therapy, And Others), By Design Type (Transcutaneous Ventricular Assist Devcies And Implantable Ventricular Assist Devices), By Type Of Flow (Pulsatile Flow And Continous Flow), By End User (Hospital And Clinics, Ambulatory Surgical Centers, And Others), by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of heart failure and cardiovascular diseases due to obesity, age, & unhealthy lifestyles and rising demand for organ transplants due to increasing prevalence of chronic ailments such as hypertension, diabetes, and others

B-cell Non-hodgkin Lymphoma Market https://www.delveinsight.com/report-store/b-cell-non-hodgkin-lymphoma-market
DelveInsight's "B-Cell Non-Hodgkin Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the B-Cell Non-Hodgkin Lymphoma, historical and forecasted epidemiology as well as the B-Cell Non-Hodgkin Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Systemic Sclerosis Market
https://www.delveinsight.com/report-store/systemic-sclerosis-market
DelveInsight's "Systemic Sclerosis Market Insights, Epidemiology, and Market Forecast - 2032" comprehensively analyzes Systemic Sclerosis. The report includes a detailed examination of the historical and projected epidemiology data that includes diagnosed prevalent cases of Systemic Sclerosis segmented by gender-specific, age-specific, and type-specific cases.

Resorbable Vascular Scaffold Market
https://www.delveinsight.com/report-store/resorbable-vascular-scaffolds-market
"DelveInsight's 'Resorbable Vascular Scaffolds Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Resorbable Vascular Scaffolds and the historical and forecasted Resorbable Vascular Scaffolds market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Vascular Stents Market
https://www.delveinsight.com/report-store/vascular-stents-market
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2028 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population.

Bladder Scanners Market
https://www.delveinsight.com/report-store/bladder-scanners-market
"DelveInsight's 'Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Vein Illumination Devices Market
https://www.delveinsight.com/report-store/vein-illumination-devices-market
"DelveInsight's 'Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Ventilator Market
https://www.delveinsight.com/report-store/ventilators-market
Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to launch of advanced devices and increasing prevalence of respiratory diseases such as COPD.

Vascular Graft Devices Market
https://www.delveinsight.com/report-store/vascular-grafts-market
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2028 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.

Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products.

Symptomatic Partial-thickness Rotator Cuff Tears Market
https://www.delveinsight.com/report-store/symptomatic-partial-thickness-rotator-cuff-tears-market
DelveInsight's "Symptomatic Partial-thickness Rotator Cuff Tears Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Symptomatic Partial-thickness Rotator Cuff Tears, historical and forecasted epidemiology as well as the Symptomatic Partial-thickness Rotator Cuff Tears market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Zika Virus Market
https://www.delveinsight.com/report-store/zika-virus-market
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Contact Us:
Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
Healthcare Consulting
https://www.delveinsight.com/consulting-services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.